BRCA1 mutation higher in Ashkenazi women:
This article was originally published in Clinica
The BRCA1 gene mutation 185delAG may account for 16% of breast cancers and 39% of ovarian cancers diagnosed in Ashkenazi women under the age of 50, new research suggests (Nature Genetics, vol 11. The deletion carrier rate was found to be at least three times higher in Ashkenazi women than in the general US population.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.